Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Buy
52,022
+21,336
+70% +$558K 0.02% 423
2026
Q1
$862K Sell
30,686
-2,664
-8% -$70.9K 0.02% 446
2025
Q4
$830K Sell
33,350
-7,144
-18% -$180K 0.03% 392
2025
Q3
$1.03M Buy
40,494
+6,519
+19% +$161K 0.03% 382
2025
Q2
$824K Sell
33,975
-61,707
-64% -$1.44M 0.02% 382
2025
Q1
$2.42M Buy
95,682
+54,129
+130% +$1.42M 0.12% 144
2024
Q4
$1.1M Buy
+41,553
New +$1.13M 0.06% 210

Other funds holding PFE

SIG Brokerage's PFE Position: Q2 2026 in Review

SIG Brokerage increased its Pfizer (PFE) stake by 70% in Q2 2026, buying an estimated $558K and bringing the position to 52,022 shares worth $1.25M. The position accounts for 0.02% of the portfolio, ranked #423.

SIG Brokerage first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.42M in Q1 2025. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • SIG Brokerage held 52,022 shares of Pfizer worth $1.25M as of Q2 2026.
  • SIG Brokerage bought 21,336 Pfizer shares in Q2 2026, an estimated $558K.
  • Pfizer made up 0.02% of SIG Brokerage's portfolio in Q2 2026, its #423 holding.
  • SIG Brokerage first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • SIG Brokerage's Pfizer position peaked at $2.42M in Q1 2025.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on SIG Brokerage's 13F filing for Q2 2026, filed 14 Aug 2026.